• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

脂蛋白(a)、绝经激素治疗与绝经后个体冠心病风险。

Lipoprotein(a), Menopausal Hormone Therapy, and Risk of Coronary Heart Disease in Postmenopausal Individuals.

机构信息

Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, Massachusetts.

Cardiology Division, Department of Medicine, Massachusetts General Hospital, Boston.

出版信息

JAMA Cardiol. 2022 May 1;7(5):565-568. doi: 10.1001/jamacardio.2022.0716.

DOI:10.1001/jamacardio.2022.0716
PMID:35377945
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8981063/
Abstract

This observational study examines whether hormone therapy use modifies the association of lipoprotein(a) with coronary heart disease.

摘要

本观察性研究旨在探讨激素疗法的使用是否会改变脂蛋白(a)与冠心病之间的关联。

相似文献

1
Lipoprotein(a), Menopausal Hormone Therapy, and Risk of Coronary Heart Disease in Postmenopausal Individuals.脂蛋白(a)、绝经激素治疗与绝经后个体冠心病风险。
JAMA Cardiol. 2022 May 1;7(5):565-568. doi: 10.1001/jamacardio.2022.0716.
2
Postmenopausal hormone-replacement therapy, plasma lipoprotein[a], and risk for coronary heart disease.绝经后激素替代疗法、血浆脂蛋白[a]与冠心病风险
J Lab Clin Med. 1994 Jun;123(6):800-3.
3
Increased plasma concentrations of TGF-beta1 after hormone replacement therapy.激素替代疗法后血浆中转化生长因子β1浓度升高。
J Intern Med. 2000 Feb;247(2):279-85. doi: 10.1046/j.1365-2796.2000.00648.x.
4
Serum lipoprotein(a) dynamics before/after menopause and long-term effects of hormone replacement therapy on lipoprotein(a) levels in middle-aged and older Japanese women.日本中老年女性绝经前后血清脂蛋白(a)的动态变化及激素替代疗法对脂蛋白(a)水平的长期影响。
Horm Metab Res. 2006 Sep;38(9):581-6. doi: 10.1055/s-2006-950504.
5
Fibrinolysis and lipoprotein(a) in women with coronary artery disease. Influence of hormone replacement therapy.冠心病女性的纤维蛋白溶解与脂蛋白(a)。激素替代疗法的影响。
Haematologica. 2001 Jan;86(1):92-8.
6
Lack of association of lipoprotein(a) levels with coronary calcium deposits in asymptomatic postmenopausal women.无症状绝经后女性中脂蛋白(a)水平与冠状动脉钙化沉积之间无关联。
J Am Coll Cardiol. 2000 Feb;35(2):314-20. doi: 10.1016/s0735-1097(99)00555-0.
7
Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause.雌激素、孕激素、脂蛋白(a)与绝经后复发性冠心病事件的风险
JAMA. 2000 Apr 12;283(14):1845-52. doi: 10.1001/jama.283.14.1845.
8
The effect of hormone replacement therapy on metabolism of lipoprotein remnants in postmenopausal women.激素替代疗法对绝经后女性脂蛋白残粒代谢的影响。
Maturitas. 2000 Jan 15;34(1):75-82. doi: 10.1016/s0378-5122(99)00087-0.
9
Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.雌激素加孕激素用于绝经后妇女冠心病二级预防的随机试验。心脏与雌激素/孕激素替代研究（HERS）研究组
JAMA. 1998 Aug 19;280(7):605-13. doi: 10.1001/jama.280.7.605.
10
Effects of postmenopausal hormone replacement therapy on lipoproteins including lipoprotein(a) and LDL subfractions.绝经后激素替代疗法对包括脂蛋白（a）和低密度脂蛋白亚组分在内的脂蛋白的影响。
Atherosclerosis. 1996 Sep 27;126(1):77-84. doi: 10.1016/0021-9150(96)05895-9.

引用本文的文献

1
Association of Lipoprotein(a) With Cardiovascular and Cerebrovascular Disease in a Nationally Representative Cohort of Germany.德国全国代表性队列中脂蛋白(a)与心血管和脑血管疾病的关联
JACC Adv. 2025 Jul 23;4(8):102015. doi: 10.1016/j.jacadv.2025.102015.
2
Sex Differences in the Association Between Lipoprotein(a) and Cardiovascular Outcomes: The MGB Lp(a) Registry.脂蛋白(a)与心血管结局关联中的性别差异：MGB Lp(a)注册研究
J Am Heart Assoc. 2025 May 6;14(9):e035353. doi: 10.1161/JAHA.124.035353. Epub 2025 Apr 16.
3
Lipoprotein(a) throughout life in women.女性一生中的脂蛋白(a)
Am J Prev Cardiol. 2024 Oct 29;20:100885. doi: 10.1016/j.ajpc.2024.100885. eCollection 2024 Dec.
4
Lipoprotein(a): Emerging insights and therapeutics.脂蛋白(a)：新见解与治疗方法
Am J Prev Cardiol. 2024 Mar 29;18:100641. doi: 10.1016/j.ajpc.2024.100641. eCollection 2024 Jun.
5
High lipoprotein(a): Actionable strategies for risk assessment and mitigation.高脂蛋白(a)：风险评估与缓解的可行策略
Am J Prev Cardiol. 2024 Apr 3;18:100651. doi: 10.1016/j.ajpc.2024.100651. eCollection 2024 Jun.
6
Lipoprotein alterations in endocrine disorders - a review of the recent developments in the field.内分泌紊乱中的脂蛋白改变——该领域的最新进展综述。
Front Endocrinol (Lausanne). 2024 Apr 2;15:1354098. doi: 10.3389/fendo.2024.1354098. eCollection 2024.
7
Lipoprotein(a) in patients with breast cancer after chemotherapy: exploring potential strategies for cardioprotection.乳腺癌患者化疗后脂蛋白(a)：探索心脏保护的潜在策略。
Lipids Health Dis. 2023 Sep 22;22(1):157. doi: 10.1186/s12944-023-01926-9.
8
Yin Huo Tang, a traditional Chinese herbal formula, relives ovariectomy and empty bottle stimulation-induced menopause-like symptoms in mice.引火汤缓解去卵巢和空瓶刺激所致的绝经综合征样小鼠模型的症状。
Front Endocrinol (Lausanne). 2022 Oct 19;13:994642. doi: 10.3389/fendo.2022.994642. eCollection 2022.
9
Lipoprotein(a): Evidence for Role as a Causal Risk Factor in Cardiovascular Disease and Emerging Therapies.脂蛋白(a)：作为心血管疾病因果风险因素的证据及新兴疗法
J Clin Med. 2022 Oct 13;11(20):6040. doi: 10.3390/jcm11206040.
10
Menopausal hormone therapy does not lower Lp(a)-associated CHD risk.更年期激素疗法不会降低与脂蛋白(a)相关的冠心病风险。
Nat Rev Cardiol. 2022 Jun;19(6):351. doi: 10.1038/s41569-022-00711-y.